Expertise in
19
conditions

Dr. Amy D. Fleischman

Pediatric Endocrinology
Division Of Endocrinology
333 Longwood Ave, 
Boston, MA 
Accepting New Patients
Referral may be required
Before you request
Expertise in
19
conditions
Division Of Endocrinology
333 Longwood Ave, 
Boston, MA 

Overview

Amy Fleischman is a Pediatric Endocrinologist practicing medicine in Boston, Massachusetts.

Dr. Fleischman is highly rated in 19 conditions, according to our data. Her clinical expertise encompasses Prader-Willi Syndrome, Short Stature (Growth Disorders), Obesity, and Idiopathic Short Stature (ISS).

She is actively involved in clinical research, co-authoring 15 peer reviewed articles and participating in 3 clinical trials. Dr. Fleischman is currently accepting new patients.

Specialties

Pediatric Endocrinology

Licenses

Pediatrics in MA

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
BMC HealthNet
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Cigna
  • EPO
  • HMO
  • PPO
Commonwealth Care Alliance
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Health New England
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Mass General Brigham Health Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • PPO
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
NH Healthy Families
  • EPO
  • MANAGED MEDICAID PLAN
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Tufts
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 13 Less Insurance Carriers -

Locations

Division of Endocrinology
333 Longwood Ave, Boston, MA 02115

Additional Areas of Focus

Dr. Fleischman has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)
Pediatric Growth Hormone Deficiency

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

An Open-Label, Long-Term Safety and Efficacy Evaluation of Diazoxide Choline Extended-Release Tablets in Participants With Prader-Willi Syndrome With a Double-Blind, Placebo-Controlled, Randomized Withdrawal Period
An Open-Label, Long-Term Safety and Efficacy Evaluation of Diazoxide Choline Extended-Release Tablets in Participants With Prader-Willi Syndrome With a Double-Blind, Placebo-Controlled, Randomized Withdrawal Period
Enrollment Status: Completed
Publish Date: April 19, 2024
Intervention Type: Drug
Study Drug: DCCR (diazoxide choline controlled release tablets)
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled Study of Diazoxide Choline Controlled-Release Tablet (DCCR) in Patients With Prader-Willi Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of Diazoxide Choline Controlled-Release Tablet (DCCR) in Patients With Prader-Willi Syndrome
Enrollment Status: Completed
Publish Date: September 21, 2023
Intervention Type: Drug
Study Phase: Phase 3
Phase 3, Randomized, Double-Blind, Placebo-Controlled, 8-week Clinical Study to Assess the Efficacy, Safety, and Tolerability, of Intranasal Carbetocin (LV-101) in Prader-Willi Syndrome (PWS) With Long Term Follow-Up (CARE-PWS)
Phase 3, Randomized, Double-Blind, Placebo-Controlled, 8-week Clinical Study to Assess the Efficacy, Safety, and Tolerability, of Intranasal Carbetocin (LV-101) in Prader-Willi Syndrome (PWS) With Long Term Follow-Up (CARE-PWS)
Enrollment Status: Completed
Publish Date: July 26, 2022
Intervention Type: Drug
Study Drug: Intranasal carbetocin
Study Phase: Phase 3
View 2 Less Clinical Trials

15 Total Publications

Overweight and obesity induce Toll-like receptor 2-induced Type I IFN signaling.
Overweight and obesity induce Toll-like receptor 2-induced Type I IFN signaling.
Journal: npj metabolic health and disease
Published: November 05, 2025
Similar Doctors
Expertise in
14
conditions
Dr. Christina M. Jacobsen
Pediatric Endocrinology
Expertise in
14
conditions
Dr. Christina M. Jacobsen
Pediatric Endocrinology
Referral may be required
Before you request

Division Of Endocrinology

333 Longwood Ave, 
Boston, MA 
 (0.1 miles away)
617-919-5323
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Christina Jacobsen is a Pediatric Endocrinologist practicing medicine in Boston, Massachusetts. Dr. Jacobsen is highly rated in 14 conditions, according to our data. Her clinical expertise encompasses Osteoporosis-Pseudoglioma Syndrome, Osteogenesis Imperfecta, X-Linked Hypophosphatemia, and Renpenning Syndrome. Dr. Jacobsen is currently accepting new patients.

Expertise in
29
conditions
Dr. Ari J. Wassner
Pediatric Endocrinology
Expertise in
29
conditions
Dr. Ari J. Wassner
Pediatric Endocrinology
Referral may be required
Before you request

Dana-Farber Cancer Institute

450 Brookline Ave, 
Boston, MA 
 (0.1 miles away)
877-442-3324
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients

Ari Wassner is a Pediatric Endocrinologist practicing medicine in Boston, Massachusetts. Dr. Wassner is highly rated in 29 conditions, according to our data. His clinical expertise encompasses Congenital Hypothyroidism, Neonatal Hypothyroidism, Multiple Endocrine Neoplasia Type 2, Thyroidectomy, and Hormone Replacement Therapy (HRT). Dr. Wassner is currently accepting new patients.

Expertise in
4
conditions
Dr. Ali K. Topaloglu
Pediatric Endocrinology
Expertise in
4
conditions
Dr. Ali K. Topaloglu
Pediatric Endocrinology
Referral may be required
Before you request

Smithkline Beecham Clin Lab

340 Wood Rd, 
Braintree, MA 
 (9.0 miles away)
617-726-2909
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Ali Topaloglu is a Pediatric Endocrinologist practicing medicine in Braintree, Massachusetts. Dr. Topaloglu is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Hypogonadotropic Hypogonadism, Hypogonadism, Intersex, and Addison's Disease. Dr. Topaloglu is currently accepting new patients.

Frequently Asked Questions about Dr. Amy D. Fleischman

How do I make an appointment with Dr. Amy D. Fleischman?

You can book an appointment with Dr. Amy D. Fleischman by calling their office at 617-919-5323. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Amy D. Fleischman a top-rated expert for Prader-Willi Syndrome?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Amy D. Fleischman is classified as an Advanced expert for Prader-Willi Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Amy D. Fleischman specialize in?

While Dr. Amy D. Fleischman is a Pediatric Endocrinology, they have specific expertise in Prader-Willi Syndrome, Short Stature (Growth Disorders), and Obesity. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pediatric Endocrinology.

Does Dr. Amy D. Fleischman participate in research or clinical trials?

Yes. Dr. Amy D. Fleischman has published 15 articles and abstracts on conditions like Prader-Willi Syndrome. You can view a list of Dr. Amy D. Fleischman's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Amy D. Fleischman accept my insurance?

Dr. Amy D. Fleischman accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 617-919-5323 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Fleischman's expertise for a condition
ConditionClose
      View All 19 Advanced Conditions
      View All 24 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile